Works matching IS 21644403 AND DT 2022 AND VI 12 AND IP 4
Results: 16
Select Ongoing Trials Currently Enrolling Patients with Esophageal Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 31
- Publication type:
- Article
Lynparza Receives FDA Approval for Adjuvant Treatment of High-Risk Early Breast Cancer with BRCA Mutation.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 30
- Publication type:
- Article
Keytruda Monotherapy FDA Approved for Endometrial Carcinoma with a Biomarker.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 30
- Publication type:
- Article
Carvykti Second BCMADirected CAR T-Cell Therapy FDA Approved for Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 29
- Publication type:
- Article
Opdualag, a Novel Immunotherapy Combination, FDA Approved for Advanced Melanoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 28
- Publication type:
- Article
Pluvicto FDA Approved for PSMA-Positive Metastatic Prostate Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 28
- Publication type:
- Article
Alum Irrigation, a Standard of Care, is Once Again Readily Available for Treatment of Hemorrhagic Cystitis.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 24
- By:
- Publication type:
- Article
Circulating Tumor DNA Profiling Useful for Diagnosing CNS Lymphoma and Guiding Treatment Selection.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 22
- By:
- Publication type:
- Article
Patient Advocacy Groups Must Find Innovative Solutions to Meet the Increasing Need for Support Services.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 20
- Publication type:
- Article
Neoadjuvant Enfortumab Vedotin Appears Promising in Patients with Muscle-Invasive Bladder Cancer Not Eligible for Cisplatin.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 17
- By:
- Publication type:
- Article
Continuous Enzalutamide Reduces Risk for Progression in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 16
- By:
- Publication type:
- Article
Study Finds 1 in 6 Patients with Cancer Experience "Long-Haul" COVID-19.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 15
- By:
- Publication type:
- Article
Pembrolizumab plus BSC Demonstrates Significant Survival Benefit in Advanced HCC.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 8
- By:
- Publication type:
- Article
Understanding the "Why" for Gen Y: What Millennials Are Looking for in Healthcare Practices.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 1
- By:
- Publication type:
- Article
It Is Time to Recall USP General Chapter <800>.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 1
- By:
- Publication type:
- Article
Novel Cancer Vaccine Shows Efficacy in Patients with Advanced Pancreatic Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 1
- By:
- Publication type:
- Article